Michail S Lionakis1. 1. Fungal Pathogenesis Section, Laboratory of Clinical Immunology & Microbiology (LCIM), National Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Abstract
PURPOSE OF REVIEW: Fungal infections cause significant mortality in patients with acquired immunodeficiencies including AIDS, hematological malignancies, transplantation, and receipt of corticosteroids, biologics or small-molecule kinase inhibitors that impair key immune pathways. The contribution of several such pathways in antifungal immunity has been uncovered by inherited immunodeficiencies featuring profound fungal susceptibility. Furthermore, the risk of fungal infection in patients with acquired immunodeficiencies may be modulated by single nucleotide polymorphisms (SNPs) in immune-related genes. This review outlines key features underlying human genetic fungal predisposition. RECENT FINDINGS: The discovery of monogenic disorders that cause fungal disease and the characterization of immune-related gene SNPs that may regulate fungal susceptibility have provided important insights into how genetic variation affects development and outcome of fungal infections in humans. SUMMARY: Recognition of individualized genetic fungal susceptibility traits in humans should help devise precision-medicine strategies for risk assessment, prognostication and treatment of patients with opportunistic fungal infections.
PURPOSE OF REVIEW: Fungal infections cause significant mortality in patients with acquired immunodeficiencies including AIDS, hematological malignancies, transplantation, and receipt of corticosteroids, biologics or small-molecule kinase inhibitors that impair key immune pathways. The contribution of several such pathways in antifungal immunity has been uncovered by inherited immunodeficiencies featuring profound fungal susceptibility. Furthermore, the risk of fungal infection in patients with acquired immunodeficiencies may be modulated by single nucleotide polymorphisms (SNPs) in immune-related genes. This review outlines key features underlying human genetic fungal predisposition. RECENT FINDINGS: The discovery of monogenic disorders that cause fungal disease and the characterization of immune-related gene SNPs that may regulate fungal susceptibility have provided important insights into how genetic variation affects development and outcome of fungal infections in humans. SUMMARY: Recognition of individualized genetic fungal susceptibility traits in humans should help devise precision-medicine strategies for risk assessment, prognostication and treatment of patients with opportunistic fungal infections.
Authors: Theo S Plantinga; Melissa D Johnson; William K Scott; Esther van de Vosse; Digna R Velez Edwards; P Brian Smith; Barbara D Alexander; John C Yang; Dennis Kremer; Gregory M Laird; Marije Oosting; Leo A B Joosten; Jos W M van der Meer; Jaap T van Dissel; Thomas J Walsh; John R Perfect; Bart Jan Kullberg; Mihai G Netea Journal: J Infect Dis Date: 2012-02-01 Impact factor: 5.226
Authors: Michail S Lionakis; Kieron Dunleavy; Mark Roschewski; Brigitte C Widemann; John A Butman; Roland Schmitz; Yandan Yang; Diane E Cole; Christopher Melani; Christine S Higham; Jigar V Desai; Michele Ceribelli; Lu Chen; Craig J Thomas; Richard F Little; Juan Gea-Banacloche; Sucharita Bhaumik; Maryalice Stetler-Stevenson; Stefania Pittaluga; Elaine S Jaffe; John Heiss; Nicole Lucas; Seth M Steinberg; Louis M Staudt; Wyndham H Wilson Journal: Cancer Cell Date: 2017-05-25 Impact factor: 31.743
Authors: Sandra Kesh; Nana Yaa Mensah; Paolo Peterlongo; Dana Jaffe; Katharine Hsu; Marcel VAN DEN Brink; Richard O'reilly; Eric Pamer; Jaya Satagopan; G A Papanicolaou Journal: Ann N Y Acad Sci Date: 2005-12 Impact factor: 5.691
Authors: Christina Gavino; Nancy Hamel; Ji Bin Zeng; Catherine Legault; Marie-Christine Guiot; Jeffrey Chankowsky; Duncan Lejtenyi; Martine Lemire; Isabelle Alarie; Simon Dufresne; Jean-Nicolas Boursiquot; Fiona McIntosh; Mélanie Langelier; Marcel A Behr; Donald C Sheppard; William D Foulkes; Donald C Vinh Journal: J Allergy Clin Immunol Date: 2015-10-29 Impact factor: 10.793
Authors: Gérard Socié; Marie-Pierre Caby-Tosi; Jing L Marantz; Alexander Cole; Camille L Bedrosian; Christoph Gasteyger; Arshad Mujeebuddin; Peter Hillmen; Johan Vande Walle; Hermann Haller Journal: Br J Haematol Date: 2019-02-15 Impact factor: 6.998
Authors: Heather R Conti; Fang Shen; Namrata Nayyar; Eileen Stocum; Jianing N Sun; Matthew J Lindemann; Allen W Ho; Justine Hoda Hai; Jeffrey J Yu; Ji Won Jung; Scott G Filler; Patricia Masso-Welch; Mira Edgerton; Sarah L Gaffen Journal: J Exp Med Date: 2009-02-09 Impact factor: 14.307
Authors: Heather R Conti; Alanna C Peterson; Lucas Brane; Anna R Huppler; Nydiaris Hernández-Santos; Natasha Whibley; Abhishek V Garg; Michelle R Simpson-Abelson; Gregory A Gibson; Anna J Mamo; Lisa C Osborne; Shrinivas Bishu; Nico Ghilardi; Ulrich Siebenlist; Simon C Watkins; David Artis; Mandy J McGeachy; Sarah L Gaffen Journal: J Exp Med Date: 2014-09-08 Impact factor: 14.307
Authors: Mariolina Bruno; Vasiliki Matzaraki; Frank L van de Veerdonk; Vinod Kumar; Mihai G Netea Journal: Infect Immun Date: 2021-07-15 Impact factor: 3.441